Keymed Biosciences Co.Ltd: Eczema trials

The registry lists 11 Eczema studies with Keymed Biosciences Co.Ltd as lead sponsor. 1 are open to participants now and 0 have results posted.

Phase 1 3Phase 2 9Phase 3 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Study of Stapokibatrt in Children Subjects With Atopic DermatitisNot yet recruitingNCT06956196Phase 3
• Study of CM310 in Children Subjects With Moderate-to-severe Atopic DermatisCompletedNCT06162507Phase 1/2
• Study of CM310 Injection in Subjects With Moderate-to-Severe Atopic DermatitisCompletedNCT05715320Phase 2
• The Study of CM326 in Adult Subjects With Atopic DermatitisStatus unknownNCT05671445Phase 2
• The Study of CM326 in Moderate-to-severe Atopic DermatitisStatus unknownNCT05671432Phase 2
• A Study of CM310 in Children Patients With Moderate-to-severe Atopic DermatisCompletedNCT05579925Phase 2
• A Study of CM310 in Patients With Moderate-to-Severe Atopic DermatitisCompletedNCT05265923Phase 3
• The Study of CM326 in Patients With Moderate-to-severe Atopic DermatitisStatus unknownNCT05186922Phase 1/2
• Dose Escalation Trial of CM310 in Patients With Moderate-to-Severe Atopic Dermatitis (AD)CompletedNCT04893941Phase 1/2
• The Study of CM310 in Patients With Atopic DermatitisCompletedNCT04893707Phase 2
• Subcutaneously CM310/Placebo in Patients With Moderate-to-Severe Atopic Dermatitis (AD)CompletedNCT04805411Phase 2